Skip to main content

Shell Asset Management Co

SEC CIK
0001211028
Latest filing
Nov 7, 2025

DNA holding history

Ginkgo Bioworks Holdings, Inc. in every 13F filed by Shell Asset Management Co, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

DNA overviewAll 13F holders of DNAFull Q3 2025 holdings

Shares (Q3 2025)
886
Value
$13.0K
% of portfolio
<0.1%
Quarters held
13
Since Q2 2022
Holdings of DNA by Shell Asset Management Co, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q3 2025886$13.0K<0.1%+43+5.1%AddedHolders
Q2 2025843$9.00K<0.1%00.0%UnchangedHolders
Q1 2025843$5.00K<0.1%−316−27.3%ReducedHolders
Q4 20241,159$11.0K<0.1%00.0%UnchangedHolders
Q3 20241,159$9.00K<0.1%–No prior filingHolders
Q2 2024––––Not filedHolders
Q1 202427,177$9.00K<0.1%−1,830−6.3%ReducedHolders
Q4 202329,007$49.0K<0.1%−8,691−23.1%ReducedHolders
Q3 202337,698$68.0K<0.1%−592−1.5%ReducedHolders
Q2 202338,290$71.0K<0.1%−225−0.6%ReducedHolders
Q1 202338,515$51.0K<0.1%−134−0.3%ReducedHolders
Q4 202238,649$65.0K<0.1%−7,247−15.8%ReducedHolders
Q3 202245,896$143.0K<0.1%−12,102−20.9%ReducedHolders
Q2 202257,998$138.0K<0.1%+57,998NewHolders